Navigation Links
Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference

What this robust clinical trial established was that nebulized formoterol fumarate, given at 20 mcg/2 mL twice daily, was well tolerated for maintenance treatment over the full 12 weeks of the trial. The side effect profile of Perforomist™ Inhalation Solution was similar to that of Foradil®, the active comparator, and the product was associated with fewer COPD exacerbations than placebo. Significantly, repeated testing for cardiac effects showed nothing to suggest a problem, a highly significant finding for the well-being of this group of patients.”

The research presented today was supported by a grant from Dey, L.P., which developed and will market Perforomist™ Inhalation Solution.

“DEY is the US leader in nebulized respiratory medication, and bringing the first nebulized formoterol fumarate to market is central to our overall strategy,” commented Mel Engle, President and CEO of DEY. “We are highly gratified by the positive safety and efficacy outcomes from the Phase III pivotal study, and thank Drs. Gross and Nelson for their careful oversight of the research and enthusiastic support of these important data. COPD patients and their families will be well served by this new treatment, which for the first time will allow twice-daily treatment with a proven LABA molecule via nebulization, a time-tested and reliable drug delivery option.”

About Perforomist™ (Formoterol Fumarate) Inhalation Solution
The clinical evaluations of Perforomist™ Inhalation Solution included two clinical trials involving a total of 1,045 patients. In the product’s pivotal Phase III trial, 351 patients participated in a 12-week, multi-center, safety and efficacy COPD study. In the study, 123 COPD patients were treated with Perforomist™ Inhalation Solution 20 mcg/2 mL twice daily, 114 COPD patients were treated with the active comparator (Foradil®), and 114 COPD patients were treated wi
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:8/21/2014)... , Aug. 21, 2014   Auxilium ... a specialty biopharmaceutical company, today announced positive results ... collagenase clostridium histolyticum (or CCH) for the treatment ... cellulite. In the Phase 2a trial, all three ... high (0.84mg)) showed an improvement in the appearance ...
(Date:8/20/2014)... LUTHERVILLE, Md. , Aug. 20, 2014 /PRNewswire/ ... today lauded the latest results achieved by the ... known as the National Precursor Log Exchange (NPLEx), ... enforcement officials track down meth offenders and make ... in Indiana blocked the ...
(Date:8/20/2014)... 20, 2014 The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful pseudoephedrine ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... venture capital and neurodevice commercialization company has opened a ... to its Cleveland, Ohio headquarters and North Carolina Research ... medical device industry veteran Mark Stultz, NDI,s recently hired ... http://photos.prnewswire.com/prnh/20111201/DC13950 ) ...
... Calif., Dec. 1, 2011  Agensys, Inc. ("Agensys"), a ... P. Hudson has been appointed vice president of ... vice president of process sciences and manufacturing. ... experience from the biopharma industry to their respective ...
Cached Medicine Technology:NDI Brings on Industry Veteran Mark Stultz to Head Up New Minneapolis Office 2Astellas Adds Two Key Senior Executives at Agensys, Inc. 2Astellas Adds Two Key Senior Executives at Agensys, Inc. 3
(Date:8/22/2014)... An increasing number of mergers and acquisitions ... market. M&As provide financial assistance to smaller companies, increase ... distribution channels of companies and help in increasing the ... According to the “ Global Animal Health Market 2014-2018 ... diet is one of the major drivers in the ...
(Date:8/22/2014)... August 22, 2014 The international ... Clinics are promoting non-invasive screening, risk assessment and ... of cardiovascular morbidity and mortality, even in asymptomatic ... Vein Thrombosis and Pulmonary Embolus, and Peripheral Vascular ... painless, noninvasive screening at accredited facilities at all ...
(Date:8/22/2014)... On October 10, 2014, Dr. ... present an in-depth workshop on mindfulness and biofeedback ... the one-day workshop, participants will learn how to ... practice. , According to Dr. Khazan, "Biofeedback is ... control their physiological responses. However, extensive research shows ...
(Date:8/22/2014)... FastFingerprints is adding a new location to the ... August 27, 2014 and is located at 3740 Euclid ... addition of this new office, that will bring the ... area. Our new Cleveland-Midtown location will provide live ... of operation will be Monday-Friday 8:00am – 5:00pm with ...
(Date:8/22/2014)... Teen substance abuse has long been a ... numbers of young adults falling victim to a drug or ... a difference in the community, the new Troubled Teens Toledo ... seeking to overcome their chemical dependency. The helpline is designed ... rehab center to focus on achieving sobriety. , By contacting ...
Breaking Medicine News(10 mins):Health News:Global Animal Health Market 2014-2018 a New Research Report Added to ReportsnReports.com 2Health News:Global Animal Health Market 2014-2018 a New Research Report Added to ReportsnReports.com 3Health News:Global Animal Health Market 2014-2018 a New Research Report Added to ReportsnReports.com 4Health News:NY Heart Health Clinics Created by Dr. David Greuner and Dr. David Luu of NYC Surgical Associates 2Health News:NY Heart Health Clinics Created by Dr. David Greuner and Dr. David Luu of NYC Surgical Associates 3Health News:Mindfulness Expert and Author Dr. Inna Khazan to Present One-day Workshop In Montreal on Integrating Mindfulness Based Skills Into a Biofeedback Practice 2Health News:Mindfulness Expert and Author Dr. Inna Khazan to Present One-day Workshop In Montreal on Integrating Mindfulness Based Skills Into a Biofeedback Practice 3Health News:FastFingerprints Expands In The Cleveland Ohio Area 2Health News:FastFingerprints Expands In The Cleveland Ohio Area 3Health News:New Helpline Provides Hope for Troubled Teens in Toledo 2
... , MARINA DEL REY, Calif., Sept. 21 ... health care formula prescribed by Dr. Richard Merkin, CEO for Heritage ... Healthcare Partners IPA in New York have been eliminating waste and ... past 30 years by focusing on the importance of integrating electronic ...
... , , ... Councilman Larry Seabrook, City Council Member for District 12 in ... Friday September 11, 2009. More than 700 residents from Co-Op ... Seabrook honoring community heroes including Mayor David Dinkins, Roscoe Brown, ...
... , , WASHINGTON, Sept. 21 ... regulation are expected as the Senate Finance Committee considers a ... offset the costs of health care reform. The amendment ... tax revenue generated through implementation of the currently pending Internet ...
... , , BELMONT, Calif., ... focused on improving the lives of patients with sleep-disordered breathing, ... the Runners-Up Award in The Wall Street Journal ... were published in the September 14, 2009 edition of ...
... Sept. 21 DHA omega-3 innovator and maker of the ... announced today that life,sDHA is featured in the new ... brand from Ragasa Industries. This is the first product launch from ... cooking oil to feature DHA for brain health. The life,sDHA ...
... follow the rules, the laws are too lax, study shows ... appear to be largely abiding by parental consent laws, but ... to harmful ultraviolet rays, a new study shows. , Tanning ... as long as they had parental consent, they could tan ...
Cached Medicine News:Health News:Heritage Provider Network and Dr. Richard Merkin Highlight Cutting Health Care Costs Using Electronic Medical Records 2Health News:HealthCare Partners, IPA, Dr. Richard Merkin, CEO and Councilman Larry Seabrook Celebrate Salute to Our Heroes on 9/11 2Health News:HealthCare Partners, IPA, Dr. Richard Merkin, CEO and Councilman Larry Seabrook Celebrate Salute to Our Heroes on 9/11 3Health News:Senator Proposes Use of Internet Gambling Revenue to Help Fund Health Care Reform 2Health News:Ventus Medical Announces PROVENT(R) Sleep Apnea Therapy Recognized by The Wall Street Journal 2009 Technology Innovation Awards 2Health News:Ventus Medical Announces PROVENT(R) Sleep Apnea Therapy Recognized by The Wall Street Journal 2009 Technology Innovation Awards 3Health News:Martek's life'sDHA(TM) Featured in New Nutrioli DHA Cooking Oil from Ragasa 2Health News:Martek's life'sDHA(TM) Featured in New Nutrioli DHA Cooking Oil from Ragasa 3Health News:Many Teens Circumvent Tanning Bed Laws 2Health News:Many Teens Circumvent Tanning Bed Laws 3
Round handle dull finish. For right handed surgeon....
Specially designed wider jaws to help split soft nucleus, cross action, round handle, maximum opening 2.8 mm....
Specially designed wider jaws to help split soft nucleus, cross action, round handle, maximum opening 2.8 mm....
Cross action, round handle, maximum opening 2.8 mm....
Medicine Products: